Skip to main content

Currently Skimming:

Appendix F: Speaker Biographies
Pages 539-548

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 539...
... In addition, David serves on the Board of Directors of Eleven Biothera peutics and works closely with several other portfolio companies. He is currently co-founder and CEO of Theracrine, a company developing novel drugs to treat metastases.
From page 540...
... Warren Distinguished Professor, University Professor, Professor of Biomedical Engineering, Professor of Medicine and Co-Director of the Center for BioDynamics at Boston University. He is also a core founding faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.
From page 541...
... at the Institute of Biotechnology, University of Cambridge, United Kingdom, during which he purified and cloned enzymes involved in biotransformations of morphine alkaloids and generated recombinant microorganisms for the bioconversion of morphine to higher-value opiate drugs. During his postdoctoral research at the University of Cambridge, he studied enzymes involved in degradation of explo sives and used these to generate biosensors for explosives and transgenic plants able to break down explosive residues in soil.
From page 542...
... National Academy of Engineering and a Fellow of American Society for Microbiology, the American Association for the Advancement of Sci ences, and the American Institute of Medical and Biological Engineers. He has received numerous awards including the AIChE Professional Progress Award for outstanding contributions to chemical engineering by an individual under 45 (2003)
From page 543...
... More recently he has turned his efforts to addressing translational and fundamental research problems in oncology. Heath has been a recipient of several awards, including the Spiers Medal from the Royal Society, a Public Service Commendation from California Governor Gray Davis, the Sackler Prize in the Physical Sciences, and the Irvin Weinstein Prize and Lectureship from the American Association of Cancer Researchers.
From page 544...
... Keasling joined the Department of Chemical Engineering at the University of California, Berkeley, as an assistant professor in 1992, where he is currently the Hubbard Howe Distinguished Professor of Biochemical Engineering. Keasling is also a professor in the Department of Bioengineering at Berkeley, a Senior Faculty Scientist and Associate Laboratory Director of the Lawrence Berkeley National Laboratory, and Chief Executive Officer of the Joint BioEnergy Institute.
From page 545...
... He is also an associate member at the Broad Institute, a member of the MIT Computational and Systems Biology Initiative and the MIT Microbial Science and Engineering Program, and a cofounder of Novophage Therapeutics. Tim's research focuses on engineering fundamental technologies to enable scalable biological systems and on applying synthetic biology to solve important medical and industrial problems, such as antimicrobial resistance and biofilms.
From page 546...
... His work at present is focused on a number of areas that include development of exchange standards in synthetic biology, exploring the potential role of computer-aided design software in synthetic biology, applying engineering principles to biological networks, and understanding the factors that contribute to the demise of engineered biological networks over evolutionary time. He was one of the founding developers of the Systems Biology Markup Language, the Systems Biology Workbench, and one of the early proponents and developers of Metabolic Control Analysis.
From page 547...
... He is presently the Editor-in-Chief of Metabolic Engineering and Current Opinion in Biotechnology and serves on the editorial boards of seven scientific journals and the advisory boards of five chemical engineering departments. He has been recognized with numerous awards (Dreyfus, Excellence in Teaching-Caltech, AIChE Technical Achievement Award, PYI, AIChE-FPBE Division Award, M.J.
From page 548...
... His research interests include integrated experimental and com putational systems biology of microorganisms, systems biology of cancer, carbon and energy metabolism, regulation of cell function, the silicon human, systems biology, and multifactorial disease. His more than 500 publications, cited more than 10,000 times, include a monograph and multiple success stories in synthetic and systems biology.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.